No abstract available.
Histamine* ; Peptic Ulcer*

No abstract available.
Mesenteric Artery, Superior* ; Superior Mesenteric Artery Syndrome*

No abstract available.
Gastrectomy*

No abstract available.
Child* ; Humans ; Infant* ; Intussusception*

Recently, we have experienced case of juxtapapillary retinal angioma. This patient was a 32-year-old Korean woman who visited our hospital because of blurred vision in her left eye for about 20 days. At the time of examination, the visual acuity of this eye was 0.3. Ophthalmoscopic examination revealed a sherical, highly vascularized tumor at the temporal margin of the optic papilla and peripapillary retinal exudates. This case was presented with a brief review of the literature.
Adult ; Exudates and Transudates ; Female ; Hemangioma* ; Humans ; Optic Disk ; Retinaldehyde* ; Visual Acuity

No abstract available.
Humans

No abstract available.
Laryngectomy* ; Speech, Esophageal*

No abstract available.

To evaluate the effect of amniotic membrane on corneal wound healing, using the VISX 193-nanometer excimer laser, the wound model of 150 micrometer depth, 6.0 mmdiameter area was created in 30 white rabbits (60 eyes). The treatment of corneal wound was categorized into three groups :topicalantibiotics alone (control), therapeutic contact lens application and amniotic membrane graft. The area of epithelial defect, proliferation of epithelial cells and inflammatory cell infiltration were evaluated during the entire observation period. Epithelial healing rates calculated by radius regression in control, contact lens and amniotic membrane groups were 42.5 micrometer/hr, 33.4 micrometer/hr and 53.4micrometer/hr respectively thus the effect of amniotic membrane was significantly outstanding (P<0.05). The epithelium was healed almost within 72 hours in eyes of amniotic membrane group but significantly delayed in contact lens group. The number of inflammatory cells in stroma were significantly lower in amniotic membrane group than others. The number of PCNA (proliferating cell nuclear antigen) immunoreactive cells has increased in amniotic membrane group than other groups and regionally at basal cell layer of limbus comparing to wound margin at first, third days after treatment. In view of the above findings, amniotic membrane on corneal wound accelerates the process of wound healing, with minimal complications.
Amnion* ; Cornea* ; Epithelial Cells ; Epithelium ; Lasers, Excimer ; Proliferating Cell Nuclear Antigen ; Rabbits ; Radius ; Transplants ; Wound Healing* ; Wounds and Injuries*

PURPOSE: To evaluate the effect of age on the efficacy and safety of holmium laser enucleation of the prostate (HoLEP) for the treatment of symptomatic benign prostatic hyperplasia (BPH). METHODS: A total of 579 patients underwent HoLEP procedure performed by a single surgeon (SJO) between December 2009 and May 2013. The perioperative and functional outcomes of patients in the age groups of 50-59 (group A, n=44), 60-69 (group B, n=253), 70-79 (group C, n=244), and ≥80 years (group D, n=38) were compared. The Clavien-Dindo system was used to evaluate clinical outcomes. The International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), postvoid residual (PVR) urine volume, and urinary continence were used to assess functional outcomes. RESULTS: In this study, the patients ≥80 years had significantly higher presence of hypertension (P=0.007), total prostate volumes (P=0.024), transitional zone volume (P=0.002), American Society of Anesthesiologists scores (P=0.006), urinary retention (P=0.032), and anticoagulation use (P=0.008) at preoperative period. Moreover, the mean values of operation time, enucleation time, morcellation time, and enucleation weight were higher in group D compared with other group patients (P=0.002, P=0.010, P<0.01, and P=0.009, respectively). Patients aged ≥80 years had a longer hospital stay time (2.9±1.8 days) than other groups (group A, 2.3±0.7 days; group B, 2.3±0.7 days vs. group C, 2.4±0.7 days; P=0.001). All groups were similar in regard to the incidence of complications (Clavien-Dindo grade) post operatively (P>0.05). All the patients in the present study showed improvement in functional outcomes after HoLEP. By the sixth month, there were no significant differences in IPSS, quality of life, Qmax, and PVR among the groups (P>0.05). CONCLUSIONS: Compared with younger patients, the patients aged ≥80 years had a similar overall morbidity and 6-month functional outcomes of HoLEP. HoLEP is a safe and effective treatment for BPH among the elderly.
Aged ; Holmium* ; Humans ; Hypertension ; Incidence ; Laser Therapy ; Lasers, Solid-State* ; Length of Stay ; Morcellation ; Preoperative Period ; Prospective Studies* ; Prostate* ; Prostatic Hyperplasia ; Quality of Life ; Transurethral Resection of Prostate ; Urinary Retention